GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00229710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 0.5mg When Added to Insulin Therapy in Patients With Type 2 Diabetes Mellitus (GALLEX 9)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 140-week open-label, multi-center long-term extension study from GALLANT 9 to monitor the safety and tolerability of oral tesaglitazar 0.5 mg and insulin in patients with type 2 diabetes during up to 140 weeks of treatment. The total duration, including treatment and follow-up, is 143 weeks.
Study identification
- NCT ID
- NCT00229710
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2005 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Dec 2006 (Actual)
- Last update posted
- Nov 19, 2010
2005 – 2006
United States locations
- U.S. sites
- 69
- U.S. states
- 30
- U.S. cities
- 69
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Tucson | Arizona | — | — |
| Research Site | Fresno | California | — | — |
| Research Site | Greenbrae | California | — | — |
| Research Site | La Jolla | California | — | — |
| Research Site | Northridge | California | — | — |
| Research Site | Riverside | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Santa Monica | California | — | — |
| Research Site | Spring Valley | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | West Hills | California | — | — |
| Research Site | Waterbury | Connecticut | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Palm Harbor | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Augusta | Georgia | — | — |
| Research Site | Dunwoody | Georgia | — | — |
| Research Site | Boise | Idaho | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Chicago Heights | Illinois | — | — |
| Research Site | Gurnee | Illinois | — | — |
| Research Site | Springfield | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Cadillac | Michigan | — | — |
| Research Site | Richmond Heights | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | North Las Vegas | Nevada | — | — |
| Research Site | Pahrump | Nevada | — | — |
| Research Site | Dover | New Hampshire | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | New Hyde Park | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Wilmington | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Kettering | Ohio | — | — |
| Research Site | Toledo | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Medford | Oregon | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Altoona | Pennsylvania | — | — |
| Research Site | Cheswick | Pennsylvania | — | — |
| Research Site | Erie | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Columbia | South Carolina | — | — |
| Research Site | Greer | South Carolina | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Fort Worth | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Roseland | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Bellevue | Washington | — | — |
| Research Site | Renton | Washington | — | — |
| Research Site | Spokane | Washington | — | — |
| Research Site | Tacoma | Washington | — | — |
| Research Site | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00229710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2010 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00229710 live on ClinicalTrials.gov.